Shanghai Pharmaceuticals Holding Co (SHSE:601607) Construction In Progress : ¥4,204 Mil (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Construction In Progress?

Shanghai Pharmaceuticals Holding Co's quarterly construction in progress declined from Sep. 2023 (¥3,973 Mil) to Dec. 2023 (¥3,570 Mil) but then increased from Dec. 2023 (¥3,570 Mil) to Mar. 2024 (¥4,204 Mil).

Shanghai Pharmaceuticals Holding Co's annual construction in progress declined from Dec. 2021 (¥2,914 Mil) to Dec. 2022 (¥2,777 Mil) but then increased from Dec. 2022 (¥2,777 Mil) to Dec. 2023 (¥3,570 Mil).

Shanghai Pharmaceuticals Holding Co Construction In Progress Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Construction In Progress Chart

Shanghai Pharmaceuticals Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

1,649.90

1,737.20

2,914.13

2,777.36

3,569.63

Shanghai Pharmaceuticals Holding Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															3,166.96	3,471.46	3,972.50	3,569.63	4,203.72

Shanghai Pharmaceuticals Holding Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

SHPMY:USA SHPMF:USA 02607:Hong Kong S1R:Germany

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Executives

Ren Jian	senior management
Liu Yan Jun	senior management
Hu Feng Xiang	Director
Zuo Min	Director
Guo Jun Yu	senior management
Han Min	senior management
Lou Ding Bo	Director
Chen Xin	Supervisors
Shu Chang	senior management
Li Yong Zhong	senior management
Jiang Yuan Ying	senior management
Xu Guo Xiong	Director
Shen Bo	senior management
Ge Jian Qiu	senior management

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines